About AllianceBernsteinome Fund (NYSE:ACG)
AllianceBernstein Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The investment objective of the Fund is high current income consistent with preservation of capital. The Fund invests its net assets in income-producing securities. The Fund invests its total assets in securities issued or guaranteed by the United States Government, its agencies or instrumentalities, and repurchase agreements pertaining to the United States Government securities. The Fund's portfolio of investments includes capital goods; communications, including media and telecommunications; consumer cyclical, including automotive, entertainment, retailers and other; consumer non-cyclical; energy; other industrial; services; technology; transportation services; financial institutions, including banking, finance, other finance and real estate investment trusts, and utilities, such as electric. AllianceBernstein L.P. is the Fund's investment advisor.
Industry, Sector and Symbol:
- Industry: Closed End Funds
- Sub-Industry: N/A
- Sector: Closed End Funds
- Symbol: NYSE:ACG
- CUSIP: N/A
- Web: N/A
- Annual Dividend: $0.37
- Dividend Yield: 4.7%
- Trailing EPS: ($0.01)
- Net Margins: -56.13%
- Return on Equity: -3.11%
- Return on Assets: -1.95%
- Outstanding Shares: 242,910,000
Frequently Asked Questions for AllianceBernsteinome Fund (NYSE:ACG)
What is AllianceBernsteinome Fund's stock symbol?
AllianceBernsteinome Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACG."
Where is AllianceBernsteinome Fund's stock going? Where will AllianceBernsteinome Fund's stock price be in 2017?
1 brokerages have issued 1 year price targets for AllianceBernsteinome Fund's shares. Their predictions range from $0.30 to $0.30. On average, they expect AllianceBernsteinome Fund's stock price to reach $0.30 in the next year. View Analyst Ratings for AllianceBernsteinome Fund.
Who are some of AllianceBernsteinome Fund's key competitors?
Some companies that are related to AllianceBernsteinome Fund include HICL Infrastructure Company Limited (HICL), Prospect Capital Corporation (PSEC), 3i Infrastructure PLC (3IN), FS Investment Corporation (FSIC), Apollo Investment Corporation (AINV), Tortoise Energy Infrastructure Corporation (TYG), TPG Specialty Lending (TSLX), John Laing Infrastructure Fund Ld (JLIF), Blackrock Taxable Municipal Bond Trust (BBN), Hercules Capital (HTGC), Golub Capital BDC (GBDC), Liberty All-Star Equity Fund (USA), New Mountain Finance Corporation (NMFC), Eaton Vance Tax-Managed Buy-Write Opportunities Fund (ETV), Solar Capital (SLRC), TCP Capital Corp. (TCPC), BlackRock Enhanced Global Dividend Trust (BOE) and Invesco California Value Municipal Income Trust (VCV).
How do I buy AllianceBernsteinome Fund stock?
Shares of AllianceBernsteinome Fund can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AllianceBernsteinome Fund's stock price today?
One share of AllianceBernsteinome Fund stock can currently be purchased for approximately $7.91.
How big of a company is AllianceBernsteinome Fund?
AllianceBernsteinome Fund has a market capitalization of $1.71 billion.
How can I contact AllianceBernsteinome Fund?
MarketBeat Community Rating for AllianceBernsteinome Fund (NYSE ACG)MarketBeat's community ratings are surveys of what our community members think about AllianceBernsteinome Fund and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
AllianceBernsteinome Fund's mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK, NY 10105-0302, United States. The investment management company can be reached via phone at +1-212-9692127.
Analysts' Consensus Ratings for AllianceBernsteinome Fund (NYSE:ACG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$0.30 (96.21% downside)|Consensus Price Target History for AllianceBernsteinome Fund (NYSE:ACG)
Analysts' Ratings History for AllianceBernsteinome Fund (NYSE:ACG)
(Data available from 11/17/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/28/2017||Fundamental Research||Initiated Coverage||Buy -> Buy||$0.30||N/A|
Earnings History for AllianceBernsteinome Fund (NYSE:ACG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for AllianceBernsteinome Fund (NYSE:ACG)
No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for AllianceBernsteinome Fund (NYSE:ACG)
|Most Recent Dividend:||2/19/2016|
|Dividend Growth:||-45.50% (3 Year Average)|
|Payout Ratio:||-3,700.00% (Trailing 12 Months of Earnings) |
Dividend History by Quarter for AllianceBernsteinome Fund (NYSE ACG)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for AllianceBernsteinome Fund (NYSE ACG)Insider Trades by Quarter for AllianceBernsteinome Fund (NYSE ACG)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/17/2017||Ian Davidson Lambert||Director||Sell||20,000||$0.13||$2,600.00|
|11/13/2017||Ian Davidson Lambert||Director||Sell||50,000||$0.13||$6,500.00|
|11/6/2017||Ian Davidson Lambert||Director||Sell||20,000||$0.10||$2,000.00|
|10/5/2017||Ian Davidson Lambert||Director||Sell||20,000||$0.12||$2,400.00|
|9/29/2017||Ian Davidson Lambert||Director||Sell||20,000||$0.10||$2,000.00|
|7/27/2017||Ian Davidson Lambert||Director||Sell||13,000||$0.16||$2,080.00|
|7/20/2017||Ian Davidson Lambert||Director||Sell||20,500||$0.14||$2,870.00|
|3/16/2017||Dennis Edward Petke||Insider||Buy||7,000||$0.10||$700.00|
|2/2/2017||Dennis Edward Petke||Insider||Sell||39,000||$0.18||$7,020.00|
|2/1/2017||Dennis Edward Petke||Insider||Sell||5,000||$0.18||$900.00|
|8/24/2015||Matthew S. Sheridan||VP||Sell||71,331||$7.92||$564,941.52|| |
|6/21/2013||Marshall C Turner||Director||Buy||27,000||$7.44||$200,880.00|| |
|6/18/2013||Paul J Denoon||VP||Buy||27,200||$7.61||$206,992.00|| |
|6/13/2013||Douglas J Peebles||VP||Buy||64,000||$7.43||$475,520.00|| |
Headline Trends for AllianceBernsteinome Fund (NYSE:ACG)
Latest Headlines for AllianceBernsteinome Fund (NYSE ACG)
AllianceBernsteinome Fund (NYSE ACG) Chart for Friday, November, 17, 2017